CytoDyn Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
CytoDyn Inc. (CYDY) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.26 per share for the 3-month period ending 2025-08-31, per its 10-Q filed 2025-10-10.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-10-10
- CytoDyn Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-08-31 was $0.26.
- CytoDyn Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2013-08-31 was $0.55, a 25.00% increase year-over-year.
- CytoDyn Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2012-08-31 was $0.44.
- CytoDyn Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2014 was $0.74, a 54.04% decline from fiscal 2013.
- CytoDyn Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2013 was $1.61, a 21.08% decline from fiscal 2012.
- CytoDyn Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2012 was $2.04.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-08-31 | $0.26 10-Q · filed 2025-10-10 | |||
| 2014-05-31 | $0.74 10-K · filed 2014-07-10 | |||
| 2014-02-28 | $0.74 10-Q · filed 2014-04-11 | |||
| 2013-11-30 | $0.74 10-Q · filed 2014-01-13 | |||
| 2013-08-31 | $0.55 10-Q · filed 2013-10-15 | |||
| 2013-05-31 | $1.61 10-K · filed 2014-07-10 | |||
| 2013-02-28 | $1.70 10-Q · filed 2013-04-12 | |||
| 2012-11-30 | $1.70 10-Q · filed 2013-01-14 | |||
| 2012-08-31 | $0.44 10-Q/A · filed 2012-11-08 | |||
| 2012-05-31 | $2.04 10-K · filed 2013-08-29 |